Breaking News Instant updates and real-time market news.

MDT

Medtronic

$84.41

-1.76 (-2.04%)

, STJ

Acquired by ABT

$78.35

-2.935 (-3.61%)

11:48
10/11/16
10/11
11:48
10/11/16
11:48

Medtronic evaluating St. Jude investigation, had similar reports, Bloomberg says

Medtronic (MDT) has had reports of lithium clusters like St. Jude (STJ), but said it uses a different battery, according to Bloomberg. Medtronic said it is evaluating the investigation of cardiac devices being conducted by St. Jude, Bloomberg added.

MDT

Medtronic

$84.41

-1.76 (-2.04%)

STJ

Acquired by ABT

$78.35

-2.935 (-3.61%)

  • 19

    Oct

  • 26

    Oct

  • 10

    Nov

MDT Medtronic
$84.41

-1.76 (-2.04%)

08/26/16
PIPR
08/26/16
NO CHANGE
PIPR
Medtronic guidance conservative, says Piper Jaffray
After Medtronic reported higher than expected Q1 EPS and in-line revenue, Piper Jaffray analyst Brooks West says the quarter was "just fine." He says that the company's failure to raise its revenue guidance to reflect recent acquisitions was conservative and "de-risks" its now "beatable" guidance. West expects new products to bolster the company's revenue, and he predicts that it will continue to gain share in CRM. He keeps a $104 price target and Overweight rating on the stock.
09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
10/05/16
WEDB
10/05/16
NO CHANGE
WEDB
Outperform
Medtronic CGM adoption could be tempered by false alarm rates, says Wedbush
Wedbush analyst Tao Levy analyzed the recently released Summary and Effectiveness Data for Medtronic's (MDT) 670G System, which he does not believe many outside of the Continuous glucose monitoring, or CGM, manufacturers have read, and came away with the belief that its new Guardian Sensor CGM standalone system suffers from a relatively large rate of false hypoglycemia alarms. While it cannot be known for sure how competitive the Guardian Sensor will be when it is eventually approved and launched in the next several months, Levy thinks elevated false alarm rates could temper adoption and that it is "too early to assume" that the product will hinder Dexcom's (DXCM) growth. The analyst keeps a Neutral rating on Medtronic and an Outperform rating on Dexcom.
STJ Acquired by ABT
$78.35

-2.935 (-3.61%)

08/29/16
FBCO
08/29/16
NO CHANGE
FBCO
St. Jude Medical can fix security deficiencies, says Credit Suisse
After speaking with "a developer of software used in drugs/devices" about Muddy Waters' security concerns regarding St. Jude's CRM system, Credit Suisse analyst Matthew Keeler says the consultant believes that the security deficiencies,can be fixed. According to the consultant, the deficiencies can be fixed using a five to ten person team working for about three months, Keeler stated. Keeler does not think that St. Jude's pending acquisition by Abbott (ABT) will be impacted by Muddy Waters' report. He keeps an $81 price target and Neutral rating on St. Jude.
09/08/16
PIPR
09/08/16
NO CHANGE
Target $82
PIPR
Neutral
Piper sees little reason to believe St. Jude deal will not close
Piper Jaffray analyst Brooks West says cybersecurity expert Mark Lanterman during a conference call yesterday refuted security claims by MedSec and Muddy Waters against St. Jude Medical's (STJ) pacemakers, defibrillators and Merlin monitoring system. Lanterman stated that there is "not much meat on the bone" to the MedSec claims and the quality of the analysis, West tells investors in a research note. He notes that Abbott (ABT) yesterday at a competitor conference earlier stated the St. Jude acquisition was progressing toward a close before year-end. The analyst sees little reason to believe the transaction will not close in the planned timeframe. West reiterates a Neutral rating on St. Jude.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.

TODAY'S FREE FLY STORIES

DAL

Delta Air Lines

$48.42

0.1 (0.21%)

14:10
09/26/17
09/26
14:10
09/26/17
14:10
Options
Delta calls outpace puts 10:1 as a bullish spread is opened »

Delta calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$65.78

1.24 (1.92%)

, UNH

UnitedHealth

$192.38

0.63 (0.33%)

14:09
09/26/17
09/26
14:09
09/26/17
14:09
Periodicals
GOP agrees not to vote on healthcare bill, CNN reports »

Senate Majority Leader…

MOH

Molina Healthcare

$65.78

1.24 (1.92%)

UNH

UnitedHealth

$192.38

0.63 (0.33%)

CNC

Centene

$92.15

1.82 (2.01%)

WCG

WellCare

$165.88

1.7305 (1.05%)

CI

Cigna

$183.10

1.66 (0.91%)

ANTM

Anthem

$183.18

1.68 (0.93%)

HNT

Health Net

HUM

Humana

$239.83

2.62 (1.10%)

AET

Aetna

$153.66

1.6785 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 17

    Oct

  • 24

    Oct

  • 08

    Nov

FL

Foot Locker

$34.77

0.11 (0.32%)

14:05
09/26/17
09/26
14:05
09/26/17
14:05
Options
Foot Locker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$88.48

0.27 (0.31%)

13:58
09/26/17
09/26
13:58
09/26/17
13:58
Hot Stocks
American Express raises quarterly dividend 9% to 35c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 18

    Oct

  • 22

    Oct

FIT

Fitbit

$6.49

0.045 (0.70%)

13:57
09/26/17
09/26
13:57
09/26/17
13:57
Hot Stocks
Fitbit to participate in FDA software pilot program »

Fitbit announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

FB

Facebook

$162.87

-7.67 (-4.50%)

, WMT

Wal-Mart

$79.48

0.33 (0.42%)

13:51
09/26/17
09/26
13:51
09/26/17
13:51
Hot Stocks
Wal-Mart to roll out Workplace by Facebook »

Julien Codorniou, the VP…

FB

Facebook

$162.87

-7.67 (-4.50%)

WMT

Wal-Mart

$79.48

0.33 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 08

    Oct

  • 10

    Oct

  • 22

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

PTEN

Patterson-UTI

$20.47

0.94 (4.81%)

13:50
09/26/17
09/26
13:50
09/26/17
13:50
Options
Put buyers active in Patterson Energy »

Put buyers active in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$162.87

-7.67 (-4.50%)

, SLF

Sun Life Financial

$39.46

0.19 (0.48%)

13:49
09/26/17
09/26
13:49
09/26/17
13:49
Hot Stocks
Sun Life Financial announces launch of Workplace by Facebook »

Sun Life Financial (SLF)…

FB

Facebook

$162.87

-7.67 (-4.50%)

SLF

Sun Life Financial

$39.46

0.19 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 03

    Oct

  • 08

    Oct

  • 22

    Oct

ELF

e.l.f. Beauty

$19.68

-0.025 (-0.13%)

, WBA

Walgreens Boots Alliance

$78.96

0.55 (0.70%)

13:46
09/26/17
09/26
13:46
09/26/17
13:46
Recommendations
e.l.f. Beauty, Walgreens Boots Alliance analyst commentary  »

e.l.f. Beauty products…

ELF

e.l.f. Beauty

$19.68

-0.025 (-0.13%)

WBA

Walgreens Boots Alliance

$78.96

0.55 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

13:45
09/26/17
09/26
13:45
09/26/17
13:45
General news
Fed funds futures slid lower on the heels of Yellen's comments »

Fed funds futures slid…

SRCI

SRC Energy

$9.18

0.36 (4.08%)

13:40
09/26/17
09/26
13:40
09/26/17
13:40
Options
Call writer opens a notable new position in SRC Energy as shares outperform »

Call writer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 16

    May

HMNY

Helios and Matheson

$8.30

1.33 (19.08%)

13:40
09/26/17
09/26
13:40
09/26/17
13:40
Periodicals
Helios and Matheson mentioned cautiously by TheStreetSweeper 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDP

Meredith

$54.05

-0.35 (-0.64%)

13:31
09/26/17
09/26
13:31
09/26/17
13:31
Hot Stocks
Meredith names Alysia Borsa chief marketing and data officer »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWP

Boardwalk Pipeline

$14.95

0.1734 (1.17%)

13:30
09/26/17
09/26
13:30
09/26/17
13:30
Options
In the money call buying continues in Boardwalk Pipeline »

In the money call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
09/26/17
09/26
13:30
09/26/17
13:30
General news
More from Yellen: not much new in her Q&A, reiterating the two sided risks »

More from Yellen: not…

NKE

Nike

13:29
09/26/17
09/26
13:29
09/26/17
13:29
Periodicals
Nike: Code left company over 3 years ago, no longer an employee, Bloomberg says »

Merl Code, the former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

13:20
09/26/17
09/26
13:20
09/26/17
13:20
General news
Treasury Action: yields steadied below highs »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

13:17
09/26/17
09/26
13:17
09/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
09/26/17
09/26
13:16
09/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$58.49

-0.06 (-0.10%)

13:15
09/26/17
09/26
13:15
09/26/17
13:15
Conference/Events
Target management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

NKE

Nike

$53.20

-0.0299 (-0.06%)

, MU

Micron

$34.87

-1.2 (-3.33%)

13:11
09/26/17
09/26
13:11
09/26/17
13:11
Earnings
Notable companies reporting after market close »

Notable companies…

NKE

Nike

$53.20

-0.0299 (-0.06%)

MU

Micron

$34.87

-1.2 (-3.33%)

CTAS

Cintas

$136.87

0.22 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

BUD

AB InBev

$117.09

0.25 (0.21%)

13:10
09/26/17
09/26
13:10
09/26/17
13:10
Options
Anheuser Busch attracts aggressive call buying »

Anheuser Busch attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$34.87

-1.2 (-3.33%)

13:09
09/26/17
09/26
13:09
09/26/17
13:09
Earnings
On The Fly: What to watch for in Micron's earnings report »

Micron (MU) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DCI

Donaldson

$45.97

-0.11 (-0.24%)

13:09
09/26/17
09/26
13:09
09/26/17
13:09
Conference/Events
Donaldson management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 30

    Oct

  • 12

    Dec

VST

Vistra Energy

$18.41

0.25 (1.38%)

, PZZA

Papa John's

$71.59

-1.37 (-1.88%)

13:06
09/26/17
09/26
13:06
09/26/17
13:06
Hot Stocks
Houston Pizza Venture reports nine-year agreement with Vistra's TXU Energy »

Houston Pizza Venture,…

VST

Vistra Energy

$18.41

0.25 (1.38%)

PZZA

Papa John's

$71.59

-1.37 (-1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.